The use of nutraceuticals in paediatric migraine

Written in association with: Dr Micheál Taylor
Published: | Updated: 09/10/2024
Edited by: Karolyn Judge

Nutraceuticals, natural products derived from food sources, are increasingly being explored as a complementary treatment for various medical conditions, including paediatric migraines. Here to tell us more is leading consultant paediatric neurologist Dr Micheál Taylor.

Boy with paediatric migraine, who could benefit from nutraceutical treatment.

What are nutraceuticals?

 

Nutraceuticals refer to supplements that include vitamins, minerals, herbal extracts, and other natural compounds that may offer therapeutic benefits. For paediatric migraine management, nutraceuticals such as magnesium, riboflavin (vitamin B2) and coenzyme Q10 (CoQ10), are some of the most commonly used. These substances are thought to play a role in improving cellular energy production, reducing oxidative stress and stabilising blood flow in the brain - all of which can help reduce migraine frequency and severity.

 

 

Why use nutraceuticals for paediatric migraines?

 

Migraine treatments for children are often limited, as many pharmaceutical options available for adults are not suitable for younger patients due to side effects or lack of research on their safety in children. Nutraceuticals offer a promising alternative, as they are generally well-tolerated and come with fewer side effects. 

 

 

Common nutraceuticals used for paediatric migraines

 

  • Magnesium: Magnesium deficiency is associated with increased migraine frequency. Supplementing with magnesium has been shown to reduce the number of migraine attacks in children. It can also help alleviate related symptoms, such as muscle tension.
  • Riboflavin (Vitamin B2): Riboflavin is essential for cellular energy production. Studies have suggested that taking riboflavin may reduce the frequency and duration of migraines in children.
  • Coenzyme Q10 (CoQ10): This antioxidant plays a key role in energy production within cells. Some evidence suggests that CoQ10 supplementation may reduce migraine frequency in children.
  • Feverfew and butterbur: These herbal extracts have anti-inflammatory properties and have been studied in the context of migraine prevention. However, they should be used cautiously in children and only under the guidance of a healthcare provider, as certain preparations may have toxic effects.

 

 

How effective and safe are nutraceuticals?

 

While Nutraceuticals are generally considered safe and well-tolerated, it is essential to note that their efficacy in treating paediatric migraines is still an area of active research. Although many studies show positive results, nutraceuticals should not be seen as a cure for migraines. Instead, they may work best as part of a comprehensive treatment plan, which can include lifestyle changes, dietary adjustments, and possibly conventional medications.

 

Parents considering nutraceuticals for their child’s migraine should consult with a paediatric neurologist or headache specialist to determine the best treatment plan. Doses need to be appropriate for the child’s age and weight, and the healthcare provider can monitor for any potential interactions with other medications.

 

Nutraceuticals offer a promising complementary approach to managing paediatric migraines, especially for children who may not respond well to traditional medications. Supplements like magnesium, riboflavin, and CoQ10 have shown potential in reducing migraine frequency and severity, though more research is needed to confirm their long-term effectiveness. Parents should always consult with a healthcare professional before starting any nutraceutical treatment for their child.

 

 

 

If you're looking for expert paediatric neurology treatment for your child, arrange a consultation with Mr Taylor via his Top Doctors profile

By Dr Micheál Taylor
Paediatric neurology

Dr Micheál (Mike) Taylor is a Consultant Paediatric Neurologist based in Leeds with an NHS practice in Leeds Children’s Hospital, which is one of the largest children’s hospitals in Europe. As a tertiary paediatric neurologist, his NHS practice encompasses a population of 5 million people throughout North, East and West Yorkshire and North-East Lincolnshire and Goole.

Dr Taylor is an expert in paediatric headache disorders with a specialised NHS headache clinic. He has a particular interest in migraine. He will soon be undertaking greater occipital nerve injections through his NHS and private practice. Dr Taylor is also undertaking clinical trials in newer therapies for the pharmacological management of migraine.

Dr Taylor is also an expert in epilepsy, with a particular interest in complex developmental epileptic encephalopathies. He runs the only Dravet Syndrome specific clinic in the UK. Dr Taylor is part of the project management committee of the SCN1A Horizons study.

Dr Taylor also runs a specialised clinic managing neuroinflammatory disorders including multiple sclerosis (MS), MOGAD, neuromyelitis optica, autoimmune encephalitis, and opsoclonus-myoclonus.

As a paediatric neurologist, Dr Taylor’s expertise extends to abnormalities of gait including toe-walking, disorders of muscle and nerve, cerebral palsy, developmental delay, and faints, fits and funny turns.

Dr Taylor also undertakes medicolegal consultations.

Dr Taylor consults privately at Nuffield Health Leeds Hospital.

Dr Taylor read medicine and completed his primary medical qualification (MBBCh BAO) with an intercalated BSc in Anatomy through Queen’s University of Belfast.

During his core paediatric neurology training in Northern Ireland, he undertook placements within paediatric neurology, paediatric neurodisability, community paediatrics, paediatric intensive care, neonatal intensive care, and general paediatrics.

Dr Taylor completed higher specialist paediatric neurology GRID training at Leeds Children’s Hospital. He is a Fellow of the Royal College of Paediatrics and Child Health. Dr Taylor is a member of both the British Paediatric Neurology Association and the European Paediatric Neurology Society.

Dr Taylor is deeply committed to medical education and clinical research. He holds the position of Honorary Senior Lecturer at the University of Leeds and his academic work has been published in various reputable journals. These include the European Journal of Paediatric Neurology, The Lancet Child and Adolescent Health, and Frontiers in Neurology.

View Profile

Overall assessment of their patients


  • Related procedures
  • Nutrition
    Allergy testing
    Congenital malformations
    Neuropsychology
    Eating disorders
    Sleep disorders
    pH monitoring
    Gastroscopy
    Polypectomy
    Bedwetting
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.